has approved the Promus Element Plus everolimus-eluting chromium platinum coronary stent (Boston Scientific), a thinner-strut stent currently approved for use in Europe. The stent, according to ...

Approval marks transition to internally manufactured everolimus-eluting stent in the U.S. NATICK, Mass., Boston Scientific Corporation announces U.S. Food and Drug Administration (FDA) approval for ...

The PROMUS Element Plus Everolimus-Eluting Platinum Chromium Coronary Stent System (Boston Scientific) was designed specifically for coronary stenting. It utilizes a proprietary platinum chromium ...

The U.S. Food and Drug Administration's approval of the Promus Element Plus chromium heart stent should add about $200 million to annualized gross margin in the U.S. and Japan by around the end of ...

Boston Scientific received CE Mark approval for the PROMUS Element Stent System in 2009 and for the PROMUS Element Plus Stent System in 2011. In the U.S., the PROMUS Element Plus Stent System ...

the PROMUS Element Stent will be commercialized as the PROMUS Element Plus Everolimus-Eluting Platinum Chromium Coronary Stent System. In the U.S., the ION Stent System and PROMUS Element Plus Stent ...

DES sales have benefited from the earlier-than-expected approval of Promus Element plus in the US (in November ... FDA approval for the Epic vascular stent, which is meant to open blocked arteries ...

May 26 Boston Scientific Corporation (NYSE: BSX) today announced the initiation of the PLATINUM PLUS clinical ... of the PROMUS(®) Element(TM) Everolimus-Eluting Coronary Stent System to the ...

Boston Scientific ($BSX) has received the FDA's OK for the Promus Element system everolimus-eluting stent, which the company will begin marketing immediately. The ...

Grines notes that European cardiology centers have also reported encountering similar problems with the Promus Element and Omega (Boston Scientific) platinum chromium coronary stents, which share ...

In the U.S., the ION Stent System and PROMUS Element Plus Stent System are investigational devices, limited by applicable law to investigational use only and not available for sale. About Boston ...

The FDA has cleared Boston Scientific’s Promus Element Plus chromium heart stent, according to a Wall Street Journal report. The company expects the approval will add $200 million to annualized gross ...